![]() Forward-looking statements speak only as of the date of this press release, and we undertake no obligation to review or update any forward-looking statement except as may be required by applicable law.Benefits pulled from the full job descriptionĤ03(b) disability insurance employee assistance program flexible spending account health insurance life insurance show 1 more benefit Actual results may differ materially from those expressed by these expectations due to risks and uncertainties. The forward-looking statements contained in this press release are based on management’s current expectations and are subject to substantial risks, uncertainty and changes in circumstances. This press release includes forward-looking statements including, but not limited to, statements related to the development of our technology, our operations and business strategy, our expected financial results, and corporate updates. For more information, please visit Forward Looking Statements Zimmons also serves as the Program Committee Chair for Women in BIO (New York Chapter) as well as board member for a family office focusing on emerging and frontier markets. ZIC’s client base is composed of emerging healthcare opportunities as well as technology, resources, and consumer health companies. Clients include both public and private entities. ZIC specializes in working with international companies as well as with portfolio companies of family offices and private equity firms. (“ZIC”) is a boutique investor relations firm based in New York founded by Jennifer K. Zimmons International Communications, Inc. For more information, please visit About Zimmons International Communications, Inc. SignPost was founded and is managed by Induran Ventures, a Venture Philanthropy General Partnership which strives to achieve both outsized returns and massive social impact through our projects. SignPost will work with both Dynacare and LabCorp to build this product. ![]() BreastDefense is a lab developed molecular test (LDT) that does not require FDA approval. (“SignPost”) is developing an advanced diagnostic breast cancer test, BreastDefense, to identify invasive breast cancer. Zimmons, Ph.D., President of Zimmons International. Supporting SignPost with its investor awareness and media campaigns will help SignPost achieve its goal of offering a solution that can help millions of women,” stated Jennifer K. Properly diagnosing invasive breast cancer is a major issue for patients, doctors, and the healthcare system. “It is a pleasure to be working with SignPost, especially during this significant period in the company’s development. We feel that these efforts will establish a name for both SignPost and BreastDefense as BreastDefense moves towards regulatory approval,” stated Peter Blaney, Chief Executive Officer of SignPost. Additionally, Zimmons International is refining our various marketing materials, raising our profile through high-quality media placements, and arranging for SignPost to be featured in various healthcare events. Zimmons International is currently introducing SignPost to a variety of family offices and impact investors. ![]() “As SignPost advances BreastDefense to identify invasive breast cancer, we believe that retaining an investor relations and communications expert is a strong strategic move. Specific emphasis will be on broadening the awareness of SignPost among family offices, impact investors, and targeted healthcare publications. Zimmons International will assist SignPost in developing and managing investor relations initiatives and activities aimed at raising SignPost’s corporate profile. (“Zimmons International”), based in New York City, as the company’s financial communications counselor and investor relations firm. (“SignPost” or “company”), a company developing an advanced diagnostic test to identify invasive breast cancer has retained Zimmons International Communications, Inc. J– Ontario, Canada – SignPost Cancer Dx Inc.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |